Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 11 open reading frame 23 pseudogene (ENSG00000230053) is a nonfunctional segment of DNA on chromosome 11 that shares sequence similarity with a functional gene but, due to disabling mutations or truncations, cannot produce a functional protein product[1][4]. Pseudogenes are typically remnants of former genes that have lost their biological activity, either through accumulated mutations or because they were generated by retrotransposition events that omit essential regulatory regions required for gene expression[2][4]. The C11orf23 pseudogene has no known biological or disease roles and is not a drug target. Key points: - The gene is a pseudogene—it is not a protein-coding gene and is unable to produce a functional protein[1][4]. - No evidence supports a role in any biological process, disease, or as a biomarker. - It is not a therapeutic target and has no pharmacological relevance. If you are seeking structured information for drug discovery or therapeutic targeting, this entry does not correspond to a valid, actionable target in current biomedical science.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 11 open reading frame 23 pseudogene (ENSG00000230053).